TABLE 2

Percentage Growth Inhibition of LNCaP Tumors Treated with 67Cu-CuSarbisPSMA as Compared with Vehicle Control

GroupGrowth inhibition (%)P
7.5 MBq 67Cu-CuSarbisPSMA100<0.001
15 MBq 67Cu-CuSarbisPSMA112<0.001
30 MBq 67Cu-CuSarbisPSMA119<0.001

  • Analysis was performed on day 13. P values were calculated relative to vehicle control.